Korean J Nephrol.  2001 Mar;20(2):332-336.

Hepatic Tuberculous Abscess and Miliary Tuberculosis in A Hemodialysis Patient

• Moon GH
• Song JH
• Lee SW
• Lee KJ
• Park HS
• Kim MJ

Abstract

The impairment of host defense mechanisms, particularly of cellular immunity, causes high incidence of mycobacterial infections in the patients with ESRD. Extrapulmonary mycobacterial infections are more frequent in ESRD patients compared to general population. However, there has been rarely reported on the occurrence of hepatic tuberculous abscess as an extrapulmonary mycobacterial infection in ESRD patients. We present a case of ESRD patient manifesting miliary tuberculosis and hepatic tuberculous abscess, which have successfully resolved after anti-tuberculous medications. A 44 years old male admitted with fever, general weakness, night sweating, and cough. Chest X-ray and abdominal CT revealed pulmonary miliary tuberculosis and a solitary tuberculous abscess at S7 of right hepatic lobe with multiple periportal and celiac lymphadenopathy. After the administration of anti-tuberculous medications(isoniazid, rifampicin, ethambutol - eight month, pyrazinamide - two month), miliary tubuculosis disappeared. The size of hepatic tuberculous abscess and lymphadenopathy were reduced in abdominal CT six month later. The patient is followed in outpatient without noticeable symptoms after eight month treatment.

Keyword

Hepatic tuberculous abscess; ESRD; Miliary tuberculosis

MeSH Terms

Abscess*
Adult
Cough
Defense Mechanisms
Ethambutol
Fever
Humans
Immunity, Cellular
Incidence
Kidney Failure, Chronic
Lymphatic Diseases
Male
Outpatients
Pyrazinamide
Renal Dialysis*
Rifampin
Sweat
Sweating
Thorax
Tomography, X-Ray Computed
Tuberculosis, Miliary*
Ethambutol
Pyrazinamide
Rifampin